lu 135252 has been researched along with Acute Necrotizing Pancreatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhr, HJ; Eibl, G; Faulhaber, J; Foitzik, T; Hotz, HG; Kirchengast, M | 1 |
| Ayuni, E; Büchler, MW; Ceyhan, GO; Friess, H; Kondo, Y; Martignoni, ME; Zimmermann, A | 1 |
| Buhr, HJ; Faulhaber, J; Foitzik, T; Hotz, HG; Kirchengast, M | 1 |
3 other study(ies) available for lu 135252 and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
[Endothelin receptor block in acute pancreatitis--improvement of microcirculation and decrease of capillary permeability also distant from the pancreas].
Topics: Animals; Blood Flow Velocity; Capillary Permeability; Endothelin Receptor Antagonists; Endothelin-1; Microcirculation; Pancreas; Pancreatitis, Acute Necrotizing; Phenylpropionates; Pyrimidines; Rats; Receptors, Endothelin | 1998 |
Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis.
Topics: Animals; Ceruletide; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Male; Pancreatitis, Acute Necrotizing; Phenylpropionates; Pyridazines; Pyrimidines; Rats; Rats, Wistar; Taurocholic Acid; Treatment Failure | 2004 |
Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.
Topics: Acute Disease; Animals; Body Fluids; Capillaries; Endothelin Receptor Antagonists; Male; Pancreas; Pancreatitis, Acute Necrotizing; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Severity of Illness Index; Survival Rate | 1998 |